- Q1 2024 Jaguar Health Inc Earnings Call TranscriptMay 14, 2024$16.49 (-5.30%)Earnings
- Q4 2023 Jaguar Health Inc Earnings Call TranscriptApr 01, 2024$4.62 (-14.35%)Earnings
- Q3 2023 Jaguar Health Inc Earnings Call TranscriptNov 14, 2023$19.89 (+6.94%)Earnings
- Jaguar Health Inc at Emerging Growth Conference (Virtual) TranscriptNov 01, 2023
- Q2 2023 Jaguar Health Inc Earnings Call TranscriptAug 14, 2023$32.09 (-6.47%)Earnings
- Ladenburg Thalmann to Host Virtual Discussion with Jaguar Health Inc TranscriptJun 22, 2023
- Jaguar Health Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Q1 2023 Jaguar Health Inc Earnings Call TranscriptMay 15, 2023$45.52 (-22.58%)Earnings
- Q4 2022 Jaguar Health Inc Earnings Call TranscriptMar 27, 2023$62.4 (-7.96%)Earnings
- Jaguar Health Inc Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Entheogen Therapeutics Initiative (ETI) - Corporate Call TranscriptJan 12, 2023
- Q3 2022 Jaguar Health Inc Earnings Call TranscriptNov 14, 2022$632.25 (-6.33%)Earnings
- Q2 2022 Jaguar Health Inc Earnings Call TranscriptAug 22, 2022$1078.2 (-10.09%)Earnings
- Q1 2022 Jaguar Health Inc Earnings Call TranscriptMay 10, 2022$1799.55 (-3.29%)Earnings
- Q4 2021 Jaguar Health Inc Earnings Call TranscriptMar 14, 2022$1697.85 (-3.26%)Earnings
- Q3 2021 Jaguar Health Inc Earnings Call TranscriptNov 17, 2021$7290 (-6.90%)Earnings
- Jaguar Health Inc at Ladenburg Thalmann R&D Webinar TranscriptSep 29, 2021
- Jaguar Health Inc Appoints Karen Brunke Corporate Update Call TranscriptSep 20, 2021
- Q2 2021 Jaguar Health Inc Earnings Call TranscriptAug 13, 2021$16740.02 (-6.77%)Earnings
- Jaguar Health Inc Business Update Call TranscriptJul 29, 2021
- Jaguar Health Inc Innovators with Jane King Webcast TranscriptJun 03, 2021
- Q1 2021 Jaguar Health Inc Earnings Presentation TranscriptMay 17, 2021
- Jaguar Health Inc Napo EU Business Overview Corporate Call TranscriptApr 23, 2021
- Jaguar Health, Inc. - Special Call TranscriptJan 27, 2021
- Jaguar Health, Inc. - Special Call TranscriptJan 14, 2021
- Jaguar Health, Inc. - Special Call TranscriptDec 17, 2020
- Q3 2020 Jaguar Health Inc Earnings Call TranscriptNov 16, 2020$2632.5 (-3.47%)Earnings
- Jaguar Health, Inc. - Special Call TranscriptOct 20, 2020
- Q2 2020 Jaguar Health Inc Earnings Call TranscriptAug 13, 2020$7468.21 (-13.47%)Earnings
- Q1 2020 Jaguar Health Inc Earnings Call TranscriptMay 15, 2020$6647.41 (-2.88%)Earnings
- Q4 2019 Jaguar Health Inc Earnings Call TranscriptApr 06, 2020$6482.71 (-4.91%)Earnings
- Jaguar Health Inc to Discuss Interim Analysis of HALT-D Study of Mytesi (Crofelemer) and Business Updates Conference Call TranscriptNov 14, 2019
- Jaguar Health, Inc. - Special Call TranscriptOct 03, 2019
Jaguar Health, Inc. - Special Call Transcript
Good day, and welcome to the Jaguar Health Investor Call. Today's conference is being recorded.
Before I turn the discussion over to the presenters, I'd like to remind you that Jaguar Health Management may make forward-looking statements relating to such matters as continued growth prospects for the company, the company's cash needs, financing plans and the company's business strategy, the likelihood, timing and scope of possible regulatory approval and commercial launch of the company's product candidates. The timing and cost of clinical trials and other expenses, uncertainties regarding market acceptance of products, the impact of competitive products and pricing, industry trends, product and technology initiatives, including product and the development stage, which may not achieve scientific objectives or meet stringent regulatory requirements and ultimate impact of current coronavirus pandemic or any other health epidemic on the company's business, its clinical trials, its research programs, or the global economy as a whole.
Forward-looking statements are subject to risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)